Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small cell lung cancer
Parmar A, Lu B, Luo J, Chan KKW. Future Oncol. 2024; May 29 [Epub ahead of print].
Parmar A, Lu B, Luo J, Chan KKW. Future Oncol. 2024; May 29 [Epub ahead of print].
Worthington J, Sun Z, Fu R, Lew JB, Chan KKW, Li Q, Eskander A, Hui H, McLoughlin K, Caruana M, Peacock S, Yong JHE, Canfell K, Feletto E, Malagón T. PLoS One. 2024; 19(4):e0296945. Epub 2024 Apr 1.
Lees CS, Seow H, Chan KKW, Gayowsky A, Merchant SJ, Sinnarajah A. Curr Oncol. 2024; 31(3):1170-82. Epub 2024 Feb 22.
He JC, Moffat GT, Podolsky S, Khan F, Liu N, Taback N, Gallinger S, Hannon B, Krzyzanowska MK, Ghassemi M, Chan KKW, Grant RC. J Clin Oncol. 2024; Feb 15 [Epub ahead of print].
Hernando-Calvo A, Nguyen P, Bedard PL, Chan KKW, Saleh RR, Weymann D, Yu C, Amir E, Regier DA, Gyawali B, Kain D, Wilson B, Earle CC, Mittmann N, Razak ARA, Isaranuwatchai W, Sabatini P, Spreafico A, Stockley TL, Pugh TJ, Williams C, Siu LL, Hanna TP. EClinicalMedicine. 2024; 69:102443. Epub 2024 Feb 12.
Arya S, Mozessohn L, Gong I, Faught N, Liu N, Singh S, Chan K, Cheung MC. Leuk Lymphoma. 2024; Jan 24 [Epub ahead of print].
Grant RC, He JC, Khan F, Liu N, Podolsky S, Kaliwal Y, Powis M, Notta F, Chan KKW, Ghassemi M, Gallinger S, Krzyzanowska MK. J Natl Compr Canc Netw. 2023; 21(10):1029–37.e21. Epub 2023 Oct 1.
Bateni SB, Nguyen P, Eskander A, Seung SJ, Mittmann N, Jalink M, Gupta A, Chan KKW, Look Hong NJ, Hanna TP. JAMA Dermatol. 2023; Sep 6 [Epub ahead of print].
Hosseini-Moghaddam SM, Shepherd FA, Swayze S, Kwong JC, Chan KKW. JAMA Netw Open. 2023; 6(8):e2331617. Epub 2023 Aug 31.
Gong I, Cheung MC, Chan KKW, Arya S, Faught N, Calzavara A, Liu N, Odejide OO, Abel G, Kurdyak P, Raphael MJ, Kuczmarski T, Prica A, Mozessohn L. J Natl Cancer Inst. 2023; Aug 2 [Epub ahead of print].